Literature DB >> 6190699

Duck hepatitis B virus and liver diseases.

M Omata, K Uchiumi, Y Ito, O Yokosuka, J Mori, K Terao, Y Wei-Fa, A P O'Connell, W T London, K Okuda.   

Abstract

The presence of duck hepatitis B virus in serum was studied in 61 ducks (24 from Chi-tung county, China, 20 from Changchun, China, and 17 from Chiba, Japan) with relation to liver disease. None of the 37 ducks from Chiba and Changchun was positive for duck hepatitis B virus as assayed by electron microscopy, endogenous deoxyribonucleic acid-polymerase activity, and hybridization with duck hepatitis B virus deoxyribonucleic acid. No liver disease was seen in these ducks. In contrast, viruslike particles were present in the serum of 12 of 24 (50%) ducks from Chi-tung, China. The presence of duck hepatitis B virus in serum was indicated by the hybridization spot test and deoxyribonucleic acid-polymerase activities. A variety of liver diseases including chronic hepatitis and cirrhosis were seen in the livers of a majority of the ducks from Chi-tung. One duck hepatitis B virus-positive duck had multicentric hepatocellular carcinoma with underlying cirrhosis. Comparison of serum duck hepatitis B virus markers and liver disease in the affected flock revealed a tendency for seronegative ducks to have advanced liver diseases. Duck hepatitis B virus infection may be used as an experimental model to test various hypotheses concerning the pathogenesis of hepatitis B virus-associated liver disease in humans.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6190699

Source DB:  PubMed          Journal:  Gastroenterology        ISSN: 0016-5085            Impact factor:   22.682


  19 in total

1.  Integrated structures of duck hepatitis B virus DNA in hepatocellular carcinoma.

Authors:  F Imazeki; K Yaginuma; M Omata; K Okuda; M Kobayashi; K Koike
Journal:  J Virol       Date:  1988-03       Impact factor: 5.103

Review 2.  The woodchuck as an animal model for pathogenesis and therapy of chronic hepatitis B virus infection.

Authors:  Stephan Menne; Paul J Cote
Journal:  World J Gastroenterol       Date:  2007-01-07       Impact factor: 5.742

3.  Hepatocellular carcinoma in ground squirrels persistently infected with ground squirrel hepatitis virus.

Authors:  P L Marion; M J Van Davelaar; S S Knight; F H Salazar; G Garcia; H Popper; W S Robinson
Journal:  Proc Natl Acad Sci U S A       Date:  1986-06       Impact factor: 11.205

4.  Duck hepatitis B virus (DHBV) infection in Indian domestic ducks: a pilot study.

Authors:  G Sridhar; T Valliammai; C S Varalakshmi; K Udayasankar; M Panchanadam; J Ramakrishna; K V Gopal; K Jayaraman; S P Thyagarajan
Journal:  Trop Anim Health Prod       Date:  1993-11       Impact factor: 1.559

5.  Duck hepatitis B virus: a model to assess efficacy of disinfectants against hepadnavirus infectivity.

Authors:  S M Murray; J S Freiman; K Vickery; D Lim; Y E Cossart; R K Whiteley
Journal:  Epidemiol Infect       Date:  1991-06       Impact factor: 2.451

6.  Duck hepatitis B virus DNA in liver and serum of Chinese ducks: integration of viral DNA in a hepatocellular carcinoma.

Authors:  O Yokosuka; M Omata; Y Z Zhou; F Imazeki; K Okuda
Journal:  Proc Natl Acad Sci U S A       Date:  1985-08       Impact factor: 11.205

7.  Liver disease associated with duck hepatitis B virus infection of domestic ducks.

Authors:  P L Marion; S S Knight; B K Ho; Y Y Guo; W S Robinson; H Popper
Journal:  Proc Natl Acad Sci U S A       Date:  1984-02       Impact factor: 11.205

8.  In vitro experimental infection of primary duck hepatocyte cultures with duck hepatitis B virus.

Authors:  J S Tuttleman; J C Pugh; J W Summers
Journal:  J Virol       Date:  1986-04       Impact factor: 5.103

Review 9.  Hepatitis B virus infection and primary hepatocellular carcinoma.

Authors:  M Feitelson
Journal:  Clin Microbiol Rev       Date:  1992-07       Impact factor: 26.132

10.  Hepatocarcinogenicity of the woodchuck hepatitis virus.

Authors:  H Popper; L Roth; R H Purcell; B C Tennant; J L Gerin
Journal:  Proc Natl Acad Sci U S A       Date:  1987-02       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.